Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary

ÉVA STÁNITZ, KRISZTINA JUHÁSZ, CSABA TÓTH, KATALIN GOMBOS, PIER GIORGIO NATALI and ISTVÁN EMBER
Anticancer Research August 2013, 33 (8) 3195-3200;
ÉVA STÁNITZ
1Transdanubian Regional National Public Health Institute, Szombathely, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KRISZTINA JUHÁSZ
2Institute of Public Health, Faculty of Medicine, University of Pécs, Pécs, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: krisztina.juhasz01@gmail.com
CSABA TÓTH
3Department of Pathology, Teaching Hospital Markusovszky, University of Pécs, Szombathely, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATALIN GOMBOS
2Institute of Public Health, Faculty of Medicine, University of Pécs, Pécs, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PIER GIORGIO NATALI
4Regina Elena National Cancer Institute, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ISTVÁN EMBER
2Institute of Public Health, Faculty of Medicine, University of Pécs, Pécs, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: Gastric cancer is among the most common causes of cancer-related death worldwide. Since microRNAs (miRNAs) represent an emerging field of cancer research, there is an increasing interest regarding the miRNA responses to environmental and lifestyle exposures. The aim of our study was to analyze whether social status, living conditions and lifestyle behaviours, such as cigarette smoking and alcohol consumption, are associated with specific miRNA expression patterns of gastric adenocarcinoma. Materials and Methods: Thirty-nine formalin-fixed paraffin-embedded primary gastric adenocarcinoma and nine non-tumourous samples were analyzed by real-time polymerase chain reaction. The expression levels of miR-21, miR-34a, miR-93, miR-143, miR-203, miR-205, miR-223 were compared in gastric adenocarcinoma samples of patients with different demographical characteristics, social status, drinking and smoking habits. Results: Overexpression of miR-21, miR-143 and underexpression of miR-34a were observed in gastric cancer samples relative to the controls. Elevated expression of miR-21 was detected in patients with low social status. Smokers showed higher expression of miR-21 and lower expression of miR-143. Up-regulation of miR-203, miR-205 and miR-223 was identified in patients with regular alcohol consumption. Patients living in an urban environment had elevated expression levels of miR-143 and miR-34a. Discussion: Differential miRNA expression patterns of gastric adenocarcinoma of the same histopathology from a small geographic region's population show homogenous correlations with the existence of common risk factors.

  • Environmental factors
  • gastric adenocarcinoma
  • gastric tumorigenesis
  • lifestyle factors
  • microRNA
  • socioeconomic factors

Gastric cancer is the fourth most frequently diagnosed cancer worldwide. Despite the decreasing incidence of stomach cancer, approximately one million new cases occur each year (1). The high-incidence areas include Eastern Asia, Eastern Europe and South America (2). Gastric adenocarcinoma is the most frequent histological subtype of this malignancy. Gastric carcinogenesis is a multistep process that also involves many environmental, genetic, epigenetic, and other factors (3). It was previously demonstrated that a low socioeconomic status, Helicobacter pylori infection, smoking, alcohol consumption and certain demographic features are associated with a high risk of gastric cancer (4, 5). There are data available on the role of genetic factors involved in the molecular pathogenesis of gastric tumour. Zhang et al. identified frequent occurrence of glutathione S-transferase pi 1 (GSTP1) Val allele in patients with gastric cancer who smoked, consumed alcohol and had Helicobacter pylori (6). In another study, the X-ray repair complementing defective repair in Chinese hamster cells 1 (XRCC1) and X-ray repair complementing defective repair in Chinese hamster cells 3 (XRCC3) gene polymorphisms showed association with smoking, drinking habits and cancer outcome (7).

MicroRNAs (miRNAs) are 18-23-nucleotide length molecules. Through binding to 3’ untranslated region of their target mRNA, they can inhibit the translation of proto-oncogenes and tumour suppressors, thus regulating signal transduction and cell-cycle processes (8). An increasing number of studies have provided evidence of the involvement of miRNAs in human tumours (9). Previous studies have reported on the association between gastric cancer development and aberrant expression of miRNAs (10-12). Based on recent evidence, miRNAs seem to have a close relationship with environmental exposures. Associations were found between miRNA de-regulation and lifestyle behaviours such as smoking and alcohol consumption, stress, infection and radiation (13). The correlation between the altered miRNA expression and the presence of such factors is essential for the better understanding of molecular mechanisms of gastric cancer development and for developing new preventative methods.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Demographical characteristics of the study groups.

Our aim was to investigate the miRNA expression profile of gastric adenocarcinoma of patients with similar clinicopathological stages of cancer but different environmental, lifestyle and social determinants, such as smoking, alcohol consumption and social status, in the Northwestern region of Hungary.

Materials and Methods

Formalin-fixed paraffin-embedded (FFPE) tumour samples were obtained from 39 patients diagnosed with gastric adenocarcinoma between 2005 and 2010 at the Oncoradiology Center of the Markusovszky County Hospital, Szombathely, Hungary. The gastric adenocarcinoma samples were selected from pathological archives at the Markusovszky County Hospital according to International Classification of Diseases (ICD) between 1500-1690 codes. Samples were classified according to the patient's social status, living conditions, drinking and smoking habits, which data were collected from the patient's medical records existing in E-MedSolution System of Markusovszky County Hospital (Table I). The median age of the patients was 62.12 years and the cohort consisted of 25 males and 14 females. The clinical stages of gastric tumour samples were the following: stage II in ten patients, stage III in nineteen, and stage IV in ten patients. Written informed consent was obtained from each patient. The study was carried out in accordance with the ethical guidelines of the Institutional Review Board.

FFPE blocks were cut into 10 μm horizontal slices. The samples were deparaffinized using xylene and 95% ethanol extraction followed by Proteinase K treatment. We isolated miRNA from tissues using High-Pure FFPE RNA Micro Kit (Roche) according to the manufacturer's protocol. RNA concentration and purity were assessed by absorption photometry at 260/280 nm. Optical density of the RNA was between 1.9 and 2.1. miRNA was reverse transcribed into cDNA using Transcriptor First-Strand cDNA Synthesis Kit (Roche). The reaction mix (20 μl) contained 2 μl template miRNA, 9 μl H2O, 2 μl of random hexamer primer, 4 μl transcriptor reverse transcriptase reaction buffer, 0.5 μl protector RNase inhibitor, 2 μl deoxynucleotide mix and 0.5 μl transcriptor reverse transcriptase. The reaction mix was heated to 80°C for 5 min to denature the RNA, followed by incubation for 30 min at 55°C. Quantitative real-time polymerase chain reaction was carried out in a Light Cycler 480 system (Roche) using Light Cycler 480 SYBR Green kit. The following primers were used: miR-21 forward: 5’-GCTTATCAGACTGATGTTGACTG-3’, reverse: 5’-CAG CCCATCGACTGGTG-3’; miR-34a forward: 5’-TGGCAGTGTCTTAGCTGGTTG-3’, reverse 5’-GGCAGTATACTTGCTGATTGCTT-3’; miR-93 forward 5’-AAGTGCTGTTCGTGCAGGT-3’, reverse: 5’-CTCGGGAAGTGCTAGCTCA-3’; miR-143 forward: 5’-TGAGGTGCAGTGCTGCATC-3’, reverse: 5’-GCTACAGTGCTTCATCTCAGACTC-3’; miR-203 forward: 5’-TCCAGTGGTTCTTAACAGTTCA-3’, reverse: 5’-GGTCTAGTGGTCCTAAACATT TC-3’; miR-205 forward: 5’-CCTTCATTCCACCGGAGT-3’, reverse: 5’GAACTTCACTCCACTGAAATCTG-3’; miR-223 forward: 5’-CCGTGTATTTGACAAGCTGAGT-3’, reverse: 5’-TGGGGTATTTGACAAACTGACA-3’. The PCR reaction mixtures included 5 μl template cDNA, 3 μl H2O, 2 μl sequence-specific primer, 10 μl Master Mix. The reaction mixtures were incubated in LightCycler 480 Multiwell Plate 96 at 95°C for 5 min, followed by 55 three-step amplification cycles (at 95°C for 10 s, at 55°C for 20 s and at 72°C for 15 s). The concentration of each miRNA was determined by absolute quantification. Independent two-sample t-test was performed for comparison between miRNA expression levels and p-Values were calculated. p-Values less than 0.05 were considered statistically significant. Values were expressed as the mean±SD. The calculation was performed using the Statistical Program for Social Science 19.0 (SPSS) software (IBM, Armonk, NY, USA).

Results

The expression levels of some miRNAs significantly differed in tumour and non-tumorous tissues. Up-regulation of miR-21 (p=0.001) and miR-143 (p=0.001) was found in gastric cancer tissues in comparison with control samples. In tumour samples, the expression level of miR-34a (p=0.001) was significantly lower than in normal tissues. We found no significant difference between tumour and normal tissues in the expression levels of miR-93, miR-203, miR-205 and miR-223 (Figure 1).

Higher expression of miR-21 was detected in patients with gastric cancer who smoked (p=0.001) and low social status (p=0.049) (Figures 2 and 3). In gastric cancer samples, the expression of miR-143 was lower in smokers (p=0.004) compared to non-smokers, while it was higher in patients with low social status (p=0.003) (Figures 2 and 3). Significantly increased expression of miR-203 (p<0.001), miR-205 (p=0.003) and miR-223 (p<0.001) was found in cancer tissues of patients who regularly consumed alcohol (Figure 4). We detected significantly lower expression levels of miR-34a (p=0.032) and miR-143 (p=0.001) in samples of patients living in villages rather than in the cities (Figure 5).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Columns represent miRNA expressions of normal and gastric cancer tissues with absolute quantification in μg/μl.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

miRNA expressions of gastric adenocarcinoma samples according to the patients' smoking habit. Columns represent miRNA expression with absolute quantification in μg/μl.

Discussion

The expression profiles of some miRNAs, including miR-21, miR-34a, miR-93, miR-143, miR-203, miR-205 and miR-223, of tumours and normal gastric tissues were determined as a first step of the analysis, then we focused on patients with gastric cancer, where the correlation between miRNA expression pattern and difference in living condition, lifestyle behaviour and social status were investigated.

By targeting oncogenes and tumor suppressor genes, miRNAs have a crucial role in carcinogenesis (14). Aberrant expression of miR-34a was found in several types of cancer such as of the colon, pancreas, breast, lung, kidney, bladder and prostate (15). miR-34a can inhibit B-cell lymphoma 2 (BCL2) and Sirtuin 1 genes, and seems to be a direct target of p53 gene (16, 17). miR-21 is known as an oncomiR, directly inhibiting the expression of phosphatase and tensin homolog (PTEN), tropomyosin 1 (alpha) (TPM1), programmed cell death 4 (PDCD4), sprouty homolog 1 (SPRY1) and sprouty homolog 2 (SPRY2) genes (18). miR-21 is involved in the pathogenesis of several types of human cancer (19). Zhang et al. demonstrated the role of miR-21 in the pathogenesis and progression of gastric cancer through regulating reversion-inducing cysteine-rich protein with kazal motifs (RECK) tumour suppressor gene in gastric cell lines. Additionally, they found overexpression of miR-21 in association with Helicobacter pylori infection in gastric cancer (20). miR-93 is a member of the miR-106B-25 cluster, which can promote tumour growth and angiogenesis in human malignancies (21). Tumor protein p53-inducible nuclear protein 1 (TP53INP1) tumour suppressor gene serves as a direct target of miR-223 (22). miR-143 was reported to have lower expression in colorectal and oesophageal tumours by inhibiting Kristen rat sarcoma 2 viral oncogene homolog (KRAS) and DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A) genes (23-25). Deregulation of miR-223 was reported first in myeloid differentiation then further investigations identified lower expression of miR-223 in different types of tumours including colorectal cancer, hepatocellular carcinoma and stomach cancer, where stathmin 1 (STMN1) is a putative target of miR-223 (26). miR-203 is also a frequently studied miRNAs, which target p63 responsible for development and maintenance of normal epithelial structures and functions (27). Altered expression of miR-203 was described in gastro-oesophageal, hepatocellular carcinoma, brain tumour, lung cancer, T-cell lymphoma, and pancreatic, breast, bladder and ovarian cancer (28). There are diverse data concerning the role of miR-205 in tumourigenesis. miR-205 can function as a tumour suppressor in oesophageal carcinoma, melanoma and breast cancer by suppressing expression of zinc finger E-box binding homeobox 1 (ZEB1) gene, E2F1 transcription factor 1 and erythroblastic leukemia viral oncogene homolog 3 (ERBB3) genes. miR-205 can promote tumour initiation, and progression by targeting PTEN, cysteine-rich angiogenic inducer 61 (CYR61) and connective tissue growth factor (CTGF) genes in nasopharyngeal carcinoma, cervical and endometrial cancer (29).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

miRNA expressions of gastric adenocarcinoma samples according to the patients' social status. Columns represent miRNA expression with absolute quantification in μg/μl.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

miRNA expressions of gastric adenocarcinoma samples according to the patients' drinking habits. Columns represent miRNA expression with absolute quantification in μg/μl.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

miRNA expression of gastric adenocarcinoma samples according the patients' living location. Columns represent miRNA expression with absolute quantification in μg/μl.

In the literature, there is an increasing number of studies reported on the deregulation of miRNAs in gastric cancer. Osawa et al. analyzed the expression of 885 miRNAs by miRNA-oligo chip in FFPE gastric samples, and found up-regulation of miR-21 in tumours, which is consistent with our study (30). They also demonstrated the overexpression of miR-34 and down-regulation of mir-143 in cancer samples related to the normal tissues, which is in contrast with our results. Two other studies by Zhang et al. and Guo et al. emphasized the importance of miR-21 as a potential biomarker in gastric cancer (31, 32). Up-regulation of miR-223 is frequently reported; however, we found no significant alteration in miR-223 expression between control and tumour samples (26, 33).

To understand how environmental and other factors influence the miRNA regulation in gastric cancer, we compared the expression levels of the same miRNAs in different groups of patients with gastric cancer and showed that differences in lifestyle, demographic features and social status can influence miRNA regulation. Higher expression of miR-203, miR-205 and miR-223 were found in gastric cancer samples from patients who regularly consumed alcohol. In samples obtained from patients who smoked and had a low social status, the expression level of miR-21 was markedly higher than in non-smokers and patients with high social status. Patients with gastric cancer living in urban areas were characterized by higher expression of miR-143 and miR-34a.

According to our results, there are considerable differences in miRNA expression patterns in gastric cancer of the same histopathological entity with respect to lifestyle behaviour, social status and demographic characteristics. This finding can contribute to a better understanding of the exact role of such factors in gastric tumourigenesis and emphasise the role of miRNAs as new molecular markers for diagnosis and prognosis of this human malignancy.

  • Received April 29, 2013.
  • Revision received May 25, 2013.
  • Accepted May 28, 2013.
  • Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Jemal A,
    2. Bray F,
    3. Center MM,
    4. Ferlay J,
    5. Ward E,
    6. Forman D
    : Global cancer statistics. CA Cancer J Clin 61(2): 69-90, 2011
    OpenUrlCrossRefPubMed
  2. ↵
    1. Bertuccio P,
    2. Chatenoud L,
    3. Levi F,
    4. Praud D,
    5. Ferlay J,
    6. Negri E,
    7. Malvezzi M,
    8. La Vecchia C
    : Recent patterns in gastric cancer: A global overview. Int J Cancer 125(3): 666-673, 2009
    OpenUrlCrossRefPubMed
  3. ↵
    1. Zheng L,
    2. Wang L,
    3. Ajani J,
    4. Xie K
    : Molecular basis of gastric cancer development and progression. Gastric Cancer 7(2): 61-77, 2004
    OpenUrlPubMed
  4. ↵
    1. Binici DN,
    2. Koca T,
    3. Dursun H
    : Dietary habits, demographical, and socio-economical risk factors of the newly diagnosed gastric cancers in the Eastern Anatolia Region of Turkey: An endemic upper gastrointestinal cancer region. Dig Dis Sci 54(12): 2629-2633, 2009
    OpenUrlCrossRefPubMed
  5. ↵
    1. Nagel G,
    2. Linseisen J,
    3. Boshuizen HC,
    4. Pera G,
    5. Del Giudice G,
    6. Westert GP,
    7. Bueno-de-Mesquita HB,
    8. Allen NE,
    9. Key TJ,
    10. Numans ME,
    11. Peeters PH,
    12. Sieri S,
    13. Siman H,
    14. Berglund G,
    15. Hallmans G,
    16. Stenling R,
    17. Martinez C,
    18. Arriola L,
    19. Barricarte A,
    20. Chirlaque MD,
    21. Quiros JR,
    22. Vineis P,
    23. Masala G,
    24. Palli D,
    25. Panico S,
    26. Tumino R,
    27. Bingham S,
    28. Boeing H,
    29. Bergmann MM,
    30. Overvad K,
    31. Boutron-Ruault MC,
    32. Clavel-Chapelon F,
    33. Olsen A,
    34. Tjonneland A,
    35. Trichopoulou A,
    36. Bamia C,
    37. Soukara S,
    38. Sabourin JC,
    39. Carneiro F,
    40. Slimani N,
    41. Jenab M,
    42. Norat T,
    43. Riboli E,
    44. González CA
    : Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Epidemiol 36(1): 66-76, 2007
    OpenUrlCrossRefPubMed
  6. ↵
    1. Zhang Y,
    2. Sun LP,
    3. Xing CZ,
    4. Xu Q,
    5. He CY,
    6. Li P,
    7. Gong YH,
    8. Liu YP,
    9. Yuan Y
    : Interaction between GSTP1 Val allele and H. pylori infection, smoking and alcohol consumption and risk of gastric cancer among the Chinese population. PLoS One 7(10): e47178, 2012.
    OpenUrlPubMed
  7. ↵
    1. Duarte MC,
    2. Colombo J,
    3. Rossit AR,
    4. Caetano A,
    5. Borim AA,
    6. Wornrath D,
    7. Silva AE
    : Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol 11(42): 6593-6600, 2005
    OpenUrlPubMed
  8. ↵
    1. Zhang B,
    2. Wang Q,
    3. Pan X
    : MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210(2): 279-289, 2007
    OpenUrlCrossRefPubMed
  9. ↵
    1. Croce CM
    : Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genetics 10(10): 704-714, 2009
    OpenUrlCrossRefPubMed
  10. ↵
    1. Pan HW,
    2. Li SC,
    3. Tsai KW
    : MicroRNA dysregulation in gastric cancer. Curr Pharm Des 19(7): 1273-1284, 2013
    OpenUrlCrossRefPubMed
    1. Song JH,
    2. Meltzer SJ
    : MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 143(1): 35-47, 2012
    OpenUrlCrossRefPubMed
  11. ↵
    1. Saito Y,
    2. Suzuki H,
    3. Hibi T
    : The role of microRNAs in gastrointestinal cancers. J Gastroenterol 44(19): 18-22, 2009
    OpenUrlPubMed
  12. ↵
    1. Wang J,
    2. Cui Q
    : Specific roles of microRNAs in their interactions with environmental factors. J Nucleic Acids 2012: 978384, 2012.
    OpenUrlPubMed
  13. ↵
    1. Iorio MV,
    2. Croce CM
    : microRNA involvement in human cancer. Carcinogenesis 33(6): 1126-1133, 2012
    OpenUrlCrossRefPubMed
  14. ↵
    1. Lodygin D,
    2. Tarasov V,
    3. Epanchintsev A,
    4. Berking C,
    5. Knyazeva T,
    6. Körner H,
    7. Knyazev P,
    8. Diebold J,
    9. Hermeking H
    : Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7(16): 2591-2600, 2008
    OpenUrlCrossRefPubMed
  15. ↵
    1. Yamakuchi M,
    2. Ferlito M,
    3. Lowenstein CJ
    : miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105(36): 13421-13426, 2008
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Tarasov V,
    2. Jung P,
    3. Verdoodt B,
    4. Lodygin D,
    5. Epanchintsev A,
    6. Menssen A,
    7. Meister G,
    8. Hermeking H
    : Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6(13): 1586-1593, 2007
    OpenUrlCrossRefPubMed
  17. ↵
    1. Buscaglia LE,
    2. Li Y
    : Apoptosis and the target genes of microRNA-21. Chin J Cancer 30(6s): 371-380, 2011.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Selcuklu SD,
    2. Donoghue MT,
    3. Spillane C
    : miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37(4): 918-925, 2009
    OpenUrlCrossRefPubMed
  19. ↵
    1. Zhang Z,
    2. Li Z,
    3. Gao C,
    4. Chen P,
    5. Chen J,
    6. Liu W,
    7. Xiao S,
    8. Lu H
    : miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88(12): 1358-1366, 2008
    OpenUrlCrossRefPubMed
  20. ↵
    1. Fang L,
    2. Deng Z,
    3. Shatseva T,
    4. Yang J,
    5. Peng C,
    6. Du WW,
    7. Yee AJ,
    8. Ang LC,
    9. He C,
    10. Shan SW,
    11. Yang BB
    : MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8. Oncogene 30(7): 806-821, 2011
    OpenUrlCrossRefPubMed
  21. ↵
    1. Fang L,
    2. Du WW,
    3. Yang W,
    4. Rutnam ZJ,
    5. Peng C,
    6. Li H,
    7. O'Malley YQ,
    8. Askeland RW,
    9. Sugg S,
    10. Liu M,
    11. Mehta T,
    12. Deng Z,
    13. Yang BB
    : MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 11(23): 4352-4365, 2012
    OpenUrlCrossRefPubMed
  22. ↵
    1. Chen X,
    2. Guo X,
    3. Zhang H,
    4. Xiang Y,
    5. Chen J,
    6. Yin Y,
    7. Cai X,
    8. Wang K,
    9. Wang G,
    10. Ba Y,
    11. Zhu L,
    12. Wang J,
    13. Yang R,
    14. Zhang Y,
    15. Ren Z,
    16. Zen K,
    17. Zhang J,
    18. Zhang CY
    : Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28(10): 1385-1392, 2009
    OpenUrlCrossRefPubMed
    1. Ng EK,
    2. Tsang WP,
    3. Ng SS,
    4. Jin HC,
    5. Yu J,
    6. Li JJ,
    7. Röcken C,
    8. Ebert MP,
    9. Kwok TT,
    10. Sung JJ
    : MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101(4): 699-706, 2009
    OpenUrlCrossRefPubMed
  23. ↵
    1. Wu BL,
    2. Xu LY,
    3. Du ZP,
    4. Liao LD,
    5. Zhang HF,
    6. Huang Q,
    7. Fang GQ,
    8. Li EM
    : MiRNA profile in esophageal squamous cell carcinoma: Down-regulation of miR-143 and miR-145. World J Gastroenterol 17(1): 79-88, 2011
    OpenUrlCrossRefPubMed
  24. ↵
    1. Li X,
    2. Zhang Y,
    3. Zhang H,
    4. Liu X,
    5. Gong T,
    6. Li M,
    7. Sun L,
    8. Ji G,
    9. Shi Y,
    10. Han Z,
    11. Han S,
    12. Nie Y,
    13. Chen X,
    14. Zhao Q,
    15. Ding J,
    16. Wu K,
    17. Daiming F
    : miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9(7): 824-833, 2011
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Lena AM,
    2. Shalom-Feuerstein R,
    3. Rivetti di Val Cervo P,
    4. Aberdam D,
    5. Knight RA,
    6. Melino G,
    7. Candi E
    : miR-203 represses ‘stemness’ by repressing DeltaNp63. Cell Death Differ 15(7): 1187-1195, 2008
    OpenUrlCrossRefPubMed
  26. ↵
    1. Chiang Y,
    2. Song Y,
    3. Wang Z,
    4. Chen Y,
    5. Yue Z,
    6. Xu H,
    7. Xing C,
    8. Liu Z
    : Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J Gastrointest Surg 15(1): 63-70, 2011
    OpenUrlCrossRefPubMed
  27. ↵
    1. Qin AY,
    2. Zhang XW,
    3. Liu L,
    4. Yu JP,
    5. Li H,
    6. Wang SZ,
    7. Ren XB,
    8. Cao S
    : MiR-205 in cancer: An angel or a devil? Eur J Cell Biol 92(2): 54-60, 2013
    OpenUrlPubMed
  28. ↵
    1. Osawa S,
    2. Shimada Y,
    3. Sekine S,
    4. Okumura T,
    5. Nagata T,
    6. Fukuoka J,
    7. Tsukada K
    : MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. Oncol Lett 2(4): 613-619, 2011
    OpenUrlCrossRefPubMed
  29. ↵
    1. Zhang Z,
    2. Li Z,
    3. Gao C,
    4. Chen P,
    5. Chen J,
    6. Liu W,
    7. Xiao S,
    8. Lu H
    : miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88(12): 1358-1366, 2008
    OpenUrlCrossRefPubMed
  30. ↵
    1. Guo J,
    2. Miao Y,
    3. Xiao B,
    4. Huan R,
    5. Jiang Z,
    6. Meng D,
    7. Wang Y
    : Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24(4): 652-657, 2009
    OpenUrlCrossRefPubMed
  31. ↵
    1. Yao Y,
    2. Suo AL,
    3. Li ZF,
    4. Liu LY,
    5. Tian T,
    6. Ni L,
    7. Zhang WG,
    8. Nan KJ,
    9. Song TS,
    10. Huang C
    : MicroRNA profiling of human gastric cancer. Mol Med Rep 2(6): 963-970, 2009
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 33 (8)
Anticancer Research
Vol. 33, Issue 8
August 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary
ÉVA STÁNITZ, KRISZTINA JUHÁSZ, CSABA TÓTH, KATALIN GOMBOS, PIER GIORGIO NATALI, ISTVÁN EMBER
Anticancer Research Aug 2013, 33 (8) 3195-3200;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary
ÉVA STÁNITZ, KRISZTINA JUHÁSZ, CSABA TÓTH, KATALIN GOMBOS, PIER GIORGIO NATALI, ISTVÁN EMBER
Anticancer Research Aug 2013, 33 (8) 3195-3200;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance
  • Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma
  • Google Scholar

More in this TOC Section

  • Platelet-derived Growth Factor Receptor-α as a Biomarker for Tongue Spindle Cell Carcinoma
  • Contrasting Role of COMMD5 in Renal Cell Carcinoma: Tumor Suppression and Metastatic Enhancement
  • Activation of DCTN1-RET Fusion Through Coiled-coil Domain as a Potential Target for RET Inhibitors
Show more Experimental Studies

Similar Articles

Keywords

  • Environmental factors
  • gastric adenocarcinoma
  • gastric tumorigenesis
  • lifestyle factors
  • microRNA
  • socioeconomic factors
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire